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Leishmania amazonensis is one of the major etiological agents of diffuse cutaneous leishmaniasis, 
which is frequently unresponsive to all known treatments. Syagrus coronata (Arecaceae) is a palm tree 
with industrial applications used in local medicine by the Brazilian “caatinga” communities. This work 
evaluates the in vitro leishmanicidal activity of S. coronata on L. amazonensis. Promastigote forms of L. 
amazonensis were treated with different concentrations of the aqueous extract from S. coronata. In 
addition, we evaluated the effect of the aqueous extract on infection of mouse peritoneal macrophages 
and nitric oxide production. The minimal inhibitory concentration (MIC) of the aqueous extract of S. 
coronata was 8.3 µg/ml. Morphological changes in L. amazonensis promastigotes treated with 50 µg/ml 
of the aqueous extract were observed by light microscopy. Pretreatment of mouse peritoneal 
macrophages with 33 µg/ml of S. coronata aqueous extract reduced the association index between 
macrophages and L. amazonensis by 70.4%, with a concomitant increase of 158.3% in nitric oxide 
production by the infected macrophages. In addition, the aqueous extract exhibited no cytotoxic effect 
on mammalian cells and elicited no allergic reactions in vivo, indicating good prospects for the 
development of new drugs of herbal origins to treat leishmaniasis.  
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INTRODUCTION 
 
Leishmaniasis is a tropical disease caused by species of 
the Leishmania genus that are spread throughout Africa, 
Asia, Europe, North America and South America, with an 
estimated 12 million people infected worldwide and a 
global incidence of 2 million new cases annually (CDC, 
2011).   Clinically,   leishmaniasis    occurs    in    visceral,  
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cutaneous and mucocutaneous forms, with 90% of the 
latter present in Afghanistan, Saudi Arabia, Algeria, 
Brazil, Iran, Iraq, Syria and Sudan (WHO, 2010). The 
New World form of the disease is mainly transmitted by 
flies of the genus Lutzomyia (Ashford, 2000). Upon 
inoculation of the host, promastigotes are phagocytized 
by skin macrophages, where they transform into ovoid 
bodies known as amastigotes. In mammals, Leishmania 
are dimorphic obligate intracellular parasites that infect 
and   multiply    primarily    within    the    phagolysosomal  
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compartment of mononuclear phagocytes (Gonçalves et 
al., 2005). Thus, the pathogenesis of Leishmania 
infection depends to a large extent on the relationship 
between the parasite and host macrophages. 
The pentavalent antimonials, which are the 
recommended drugs for the treatment of cutaneous 
leishmaniasis, were first introduced 60 years ago; 
however, serious side effects and the emergence of 
resistant strains limit their effectiveness (Croft et al., 
2006a, b). In addition, these drugs require parenteral 
administration and are toxic and expensive, with a 
restricted therapeutic spectrum for all clinical forms of 
leishmaniasis (Davis et al., 2004). The lack of an effective 
leishmanicidal drug has evoked a renewed interest in 
medicinal plants as sources of new chemotherapeutic 
compounds that are more effective and have fewer side 
effects (Tiuman et al., 2005). 
In every country, traditional medicines are ingrained in 
magical or religious beliefs or in popular experience, and 
the World Health Organization (WHO) is currently 
devising guidelines for clinical research methodologies 
and appraisal of the effectiveness of traditional medicines 
(Firenzuoli and Gori, 2007). Brazil not only has one of the 
world’s highest degree of biodiversity, but it also has an 
enormous cultural diversity and an as yet under-utilized 
repertoire of plants with a potential economic value 
(Albuquerque et al., 2007). The “caatinga” (Brazilian 
semi-arid) possess ecological characteristics that are well 
known to many arid regions, including low relative 
humidity, high temperatures and by rather unpredictable 
seasonality of rains. The “caatinga” vegetation is a highly 
threatened biome covering a vast area in northeastern 
Brazil and is the source of many little-studied natural 
resources (Araújo et al., 2007). Many medicinal plant 
species from the “caatinga” are widely known and used in 
folk medicine and for commercial manufacturing of 
phytotherapeutic products, including the following: 
Myracrodruon urundeuva Allemão, Amburana cearensis 
(Arr. Cam.) A.C. Smith, Erythrina velutina Willd., 
Anadenanthera colubrina (Vell.) Brenan var. cebil 
(Griseb) Altschul, and Sideroxylon obtusifolium (Roem. 
and Schult.) T.D. Penn (Albuquerque and Oliveira, 2007). 
Syagrus coronata (C. Martius) Becc. (Palmae) is a palm 
tree of South American distribution. In Brazil, this palm 
tree appears mainly along the coastal area of the state of 
Bahia and grows to approximately 10 m tall, with a crown 
of arching, semi-plumose leaves. The “licuzeiro”, as S. 
coronata is popularly known, is an economically 
important palm tree grown as an ornamental, for the oil 
extracted from its seeds and for the wax from its leaves, 
which has several industrial applications (Lins et al., 
2002). The flowers and fruits of S. coronata are used in 
folk medicine to treat dysentery and cataracts 
(Albuquerque et al., 2007); however, at present, there are 
no scientific reports regarding the pharmacological 
activity of S. coronata. Thus, the aim of the present study 
was to investigate the activity of an aqueous extract of S. 
coronata against L.  amazonensis  parasites  and  its  effects  
 
 
 
 
on macrophage infection and nitric oxide (NO) 
production. 
 
 
MATERIALS AND METHODS 
 
Plant material 
 
Syagrus coronata coconut fruits, commonly known as “licuri”, were 
collected in Santa Luz, state of Bahia, Brazil (Long.: -39:21:52.89; 
Lat.: -11:14:35.67; height above sea level: 370 m) and 
authenticated by Dr. Larry Noblick, Herbário da Universidade 
Estadual de Feira de Santana, Bahia (Brazil), where a voucher 
specimen is deposited (HUEFS n. 63069).  
 
 
Polyphenolic extract 
 
The wet coconut husk (20 g) was finely ground and soaked for 1 h 
in 300 ml of boiling distilled water. The extract was filtered and 
lyophilized, yielding 1.3 g of crude aqueous extract. The extract was 
then dissolved in RPMI medium at 1 mg/ml dilution and sterilized by 
filtration using a 0.22 µm Millipore membrane prior to use in 
leishmanicidal assays. This S. coronata crude aqueous extract, 
prepared as described, was used for all assays throughout this 
study. 
 
 
Characterization of procyanidins 
 
The crude aqueous extract was subjected to HPLC/DAD analysis, 
according to a protocol devised by Peng et al. (2001) to analyze 
procyanidins in grape seeds. Samples (20 µl) were loaded onto a 
4.6 x 250 mm C18 column (Exsil 100 5 µ ODS, Activon, Sydney, 
Australia) with a C18 guard cartridge with the same packing material 
equilibrated in solvent A [0.2% (v/v) phosphoric acid]. Phenolic 
compounds were eluted with a gradient of solvent B [82% (v/v) 
acetonitrile, 0.04% (v/v) phosphoric acid] as follows: 0 to 15% 
solvent B in the first 15 min, 15 to 16% from 15 to 40 min, 16 to 
17% from 40 to 45 min, 17 to 43% from 45 to 48 min, 43 to 52% 
from 48 to 49 min, held isocratic at 52% from 49 to 56 min, reduced 
from 52 to 43% from 56 to 57 min, and finally reduced from 17 to 
0% from 58 to 60 min. Peaks were detected at 280 nm and 
identified by comparison with the retention times of standards. 
The concentration of procyanidins in the sample solution of S. 
coronata lyophilized crude aqueous extract was determined by the 
vanillin-HCl assay (Nakamura et al., 2003). Briefly, 2.5 ml of 
methanol (control) or 1% vanillin solution in methanol (sample) and 
2.5 ml of 9 M HCl in methanol was added to a test tube containing 1 
ml of catechin solution (0 to 300 µg/ml in methanol) or test solution 
(150 to 250 µg/ml polyphenols in methanol). The reaction mixture 
was incubated for 20 min at 30°C, and the absorbance at 500 nm 
was measured. The absorbance was calculated as follows for each 
standard and sample solution: a calibration curve was prepared 
using the calculated absorbance for the catechin solution, and the 
total procyanidin in each test solution was calculated from the 
calibration curve. 
 
 
Parasite culture 
 
Promastigote forms of Leishmania amazonensis (Raimundo strain 
MHOM/BR/76/Ma–5) were maintained by weekly subculturing in 
PBHIL medium (Rodrigues et al., 2010) supplemented with 10% 
fetal bovine serum (FBS), at 26°C. Infectivity of the parasites was 
maintained by periodic hamster footpad inoculation. 
  
 
 
Leishmanicidal activity 
 
Promastigotes of L. amazonensis (106 parasites/ml) were incubated 
in RPMI medium in the absence or presence of 50 µg/ml of crude 
aqueous extract from the coconut husk of S. coronata at 37°C, and 
parasite survival and cell morphology were evaluated by optical 
microscopy at 10 min intervals. Parasite viability was assessed 
before and after incubation by motility and by trypan blue exclusion, 
using a hemocytometer chamber.  
Cell viability was determined using the following formula: [100 – 
(L2 / L1)]×100, where L1 is the percentage of viable control cells 
and L2 is the percentage of viable treated cells, as previously 
described (Delorenzi, 2001). Alternatively, after 30 min of parasite 
growth in the presence of the S. coronata coconut husk aqueous 
extract (16 µg/ml), cells were centrifuged and washed three times in 
PBS prior to resuspension in new culture medium without the plant 
extract to evaluate the leishmanicidal or leishmanistatic effect. 
Growth was determined by counting the cells over a 120 h period of 
incubation in vitro. 
 
 
Minimum inhibitory concentration (MIC) evaluation 
 
L. amazonensis promastigotes (106 parasites/ml) were incubated in 
fresh medium (PBHIL) supplemented with 10% FBS in the absence 
or presence of several concentrations (1 µg/ml to 1 mg/ml) of 
aqueous extract from the coconut husk of S. coronata at 26°C for 
120 h (cell growth was determined daily by assessment of visible 
turbidity). MIC was considered the lowest concentration of the 
aqueous extract that prevented the growth of L. amazonensis in 
vitro. Parasite growth was determined daily using a hemocytometer 
chamber.  
 
 
Mouse peritoneal macrophages 
 
Non-elicited peritoneal macrophages from female Swiss mice (6 to 
8 weeks of age) were collected in cold PBS (150 mM NaCl; 20 mM 
phosphate buffer, pH 7.2) and allowed to adhere to coverslips 
placed in 24 well culture plates for 30 min at 37°C in a 5% CO2 
atmosphere. Non-adherent cells were then removed, and the 
adhered macrophages were washed twice with PBS and cultured 
for 24 h in culture medium (RPMI) (GIBCO BRL, Gaithersburg, MD, 
USA) supplemented with 10% FBS.  
 
 
Infection of macrophages and nitric oxide production 
 
Mouse peritoneal macrophages were obtained as described 
previously. Parasites and/or macrophages were either treated with 
16 and 33 µg/ml of aqueous extract from S. coronata or untreated 
for 20 min prior to the macrophage-parasite interactions. Adherent 
cultured macrophages and free parasites were washed once and 
resuspended in fresh RPMI culture medium. Intact, live L. 
amazonensis promastigotes were then added to macrophages in 
culture plates. Parasite-macrophage interactions were conducted at 
37°C for 90 min using parasites and/or macrophages pretreated 
with the aqueous extract. An MOI of 10 was used for all infection 
assays. 
After interaction assays were completed, coverslips were fixed and 
Giemsa stained, and the percentage of infected macrophages was 
determined by counting 600 cells on triplicate coverslips. The 
association indices were determined by multiplying the percentage 
of infected macrophages by the mean number of parasites per 
infected cell. The association index was considered to be the 
number of parasites that successfully infected the macrophages. 
The supernatants from control (macrophages in culture only) and L. 
amazonensis–infected macrophages were analyzed for  their  nitrite  
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content by the Griess reaction as previously described (Grynberg et 
al., 1999). The absorbance at 550 nm was measured, and the 
concentration of nitrite was calculated using a linear regression of a 
standard curve. To obtain mouse peritoneal macrophages both for 
infections with Leishmania and for nitric oxide measurements, mice 
were sacrificed according to all federal guidelines and institutional 
policies. 
 
 
Anti-intracellular amastigote activity 
 
To evaluate the effect of the aqueous extract on intracellular 
amastigotes, macrophages were infected with L. amazonensis 
promastigotes (logarithmic growth phase) at a multiplicity of 
infection (MOI) of 10 and incubated for 90 min at 37°C in 5% CO2. 
Next, free promastigotes were removed by extensive washing with 
PBS, and the infected macrophages were then incubated for 24 h 
to allow for complete promastigote differentiation into intracellular 
amastigotes. The infected macrophages were then treated with the 
aqueous extract (16 and 33 µg/ml) for 20 min. After treatment, 
culture supernatants were collected for NO analysis, and coverslips 
were fixed as described above.  
 
 
Cytotoxicity assay 
 
The cytotoxicity of the aqueous extract toward macrophages was 
measured using the neutral red uptake assay. Briefly, macrophages 
were cultivated in 96 well microtiter plates (150 µl containing 105 
cells/ml in EAGLE-MEM medium/well) at 37°C in a humidified 5% 
CO2 atmosphere. The medium was supplemented with L-glutamine 
(0.10 g/L), HEPES (2.38 g/L), penicillin G (105 IE/L), streptomycin 
sulfate (0.10 g/L) and 4% FBS. After a 24 h incubation, 50 µl of 33 
µg/ml aqueous extract was added to the cultures, and 50 µl of 
EAGLE-MEM medium was added to the control cells. 
After further incubation for 48 h, control and treated cells were 
washed three times with PBS (pH 7.2), and 100 µl of neutral red 
solution (0.3% in EAGLE-MEM) was added to each well. After a 3 h 
incubation at 37°C with the neutral red solution, the cells were 
again washed three times with PBS. Finally, 100 µl of a solution of 
1% acetic acid and 50% ethanol was added to the wells, and the 
optical density (OD) of the supernatants was measured at 540 nm. 
 
 
In vivo primary dermal irritation, cumulative dermal irritation 
and ocular irritation tests 
 
For each irritation test, 3 Balb/c mice (6 to 8 weeks of age) were 
used. To perform the dermal tests, we selected 2 different shaved 
and gently scraped regions (right and left) that were approximately 
6 mm in diameter on the back of each mouse. In the primary 
irritation test, we used a small volume (0.04 ml) of sterile S. 
coronata aqueous extract (100µg/ml). The treatment sites were 
observed after application of the extract and over the subsequent 7 
days. In the cumulative dermal irritation tests, we added 0.5 ml of S. 
coronata extract (100 µg/ml) daily after the first application. For the 
ocular irritation test, we dropped 0.05 ml of the extract (100 µg/ml) 
in both eyes and monitored inflammation at 24, 48 and 72 h post-
application. 
 
 
Statistical analysis 
 
All experiments were performed in triplicate. The mean and 
standard error of at least three experiments were determined. The 
differences between the mean values obtained for experimental 
groups was evaluated by the Student’s t test. P-values of 0.05 or 
less were considered significant. 
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Figure 1. A trace of reverse phase HPLC analysis of S. coronata lyophilized crude aqueous extract. The 
asterisk () in the figure indicates polymeric procyanidins (Rodrigues et al., 2011). 
 
 
 
RESULTS 
 
Aqueous extract analysis 
 
The lyophilized crude aqueous extract was analyzed by 
HPLC. The chromatogram (Figure 1) features a late-
eluting broad peak. According to the protocol devised by 
Peng et al. (2001) for the analysis of tannins, this elution 
behavior and UV absorption characteristics indicate the 
presence of polymeric procyanidins. The vanillin-HCl 
assay is highly specific for procyanidins and involves 
acidic hydrolysis of the condensed tannins followed by 
coupling of the flavanol units to vanillin. Polymeric 
procyanidins were detected at a concentration of 146 
mg/g of aqueous extract. 
 
 
Minimum inhibitory concentration 
 
The lowest concentration of the S. coronata crude 
aqueous extract that abrogated the growth of L. 
amazonensis promastigote forms was 8.3 µg/ml.  
 
 
Leishmanicidal activity 
 
A time course of the viability of L. amazonensis 
promastigotes and of mouse peritoneal macrophages in 
the absence or presence of S. coronata crude aqueous 
extract is shown in Figure 2. At a concentration of 50 
µg/ml, the S. coronata crude aqueous extract was able to 
kill 100% of L. amazonensis promastigotes in 60 min with 
no toxicity toward mouse macrophages (Figure 2). 
Increased cellular volume was noted among parasites 
exposed to the aqueous extract,  followed  by  membrane 
disruption (Figure 3). In addition, after a 30 min 
incubation with the aqueous extract, parasites were no 
longer able to grow in fresh medium. 
 
 
Infection of macrophages 
 
Figure 4 shows the effects of the crude aqueous extract 
on the interaction between L. amazonensis and 
macrophages. Before co-culture, parasites and/or mouse 
peritoneal macrophages were treated with two different 
concentrations of S. coronata crude aqueous extract (16 
and 33 µg/ml) for 20 min or left untreated (Figure 4A). 
The crude aqueous extract was able to reduce the 
association indices in all systems tested. When 
macrophages were pretreated with 16 or 33 µg/ml of the 
crude aqueous extract and incubated with untreated 
parasites, association indices were 37 and 70.4% lower 
than the controls (untreated macrophages and parasites), 
respectively. When parasites were pretreated with 16 or 
33 µg /ml of the crude aqueous extract and incubated 
with untreated macrophages, the association indices 
decreased 21.8 and 54.3% compared to the control 
system, respectively, similar to the results obtained for 
the co-culture of pretreated macrophages with pretreated 
parasites (34.1 and 51.8%, respectively). Finally, when 
macrophages were infected with L. amazonensis, 24 h 
prior to treatment with 16 or 33 µg/ml of the crude 
aqueous extract, the association indices were 52.3 and 
71% lower than the control, respectively (Figure 4B). 
 
 
Nitric oxide production 
 
Culture  supernatants  of  mouse peritoneal macrophages 
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Figure 2. Time course of the viability of promastigote forms of Leishmania amazonensis 
and mouse peritoneal macrophages in the absence or presence of the aqueous extract 
from S. coronata. The viability (%) of parasites and macrophages was calculated as [100 
– (L2/L1)] × 100, where L1 is the percentage of viable control cells and L2 is the 
percentage of viable treated cells. (●) L. amazonensis promastigotes (control); (○) L. 
amazonensis promastigotes + S. coronata aqueous extract at 50 µg/ml; () mouse 
peritoneal macrophages (control); () mouse peritoneal macrophages + S. coronata 
aqueous extract at 50 µg/ml (Rodrigues et al., 2011). 
 
 
 
 
 
Figure 3. Microscopic observation of the viability time course of L. amazonensis 
promastigote forms incubated with 50 µg/ml S. coronata aqueous extract. (A) Control 
parasites; (B) parasites treated for 20 min; (C) parasites treated for 40 min; (D) 
parasites treated for 60 min. Note the increase in cell volume (arrows in B and C) and 
the complete lysis of the parasite cell (D). Scale bar, 20 µm (Rodrigues et al., 2011). 
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Figure 4. Effects of S. coronata aqueous extract on the Leishmania amazonensis-macrophage interaction. Parasites and/or 
mouse peritoneal macrophages were either treated with 16 µg/ml (black bars) or 33 µg/ml (gray bars) of S. coronata 
aqueous extract or untreated (white bar) 20 min prior to the co-culture of macrophages and parasites (A). The adherent 
cultured macrophages and the free parasites were washed once and resuspended in fresh culture medium. Intact, live L. 
amazonensis promastigotes were then added to the macrophages in culture plate wells. Macrophages previously infected 
with L. amazonensis were treated with the aqueous extract (16 and 33 µg/ml) for 20 min and then incubated for 90 min at 
37°C in 5% CO2 (B). Association indices were determined by light microscopy by counting 600 cells on triplicate coverslips 
after 90 min of interaction. Each bar represents the mean ± standard error of at least three independent experiments, which 
were performed in triplicate. Association indices of assays performed using pretreated macrophages and/or pretreated 
parasites with S. coronata extract are significantly different from the association index of control (untreated) macrophages. 
(MØ) macrophages; (P) parasites; (PtMØ) pretreated macrophages; (PtP) pretreated parasites; (Post-tMØ) post-treated 
infected macrophages (Rodrigues et al., 2011). 
 
 
 
were treated with 16 or 33 µg/ml of the aqueous extract 
produced 40.6 and 60.1% more nitric oxide than control 
(uninfected and untreated) macrophages. Infected 
macrophages produced 80.4% more nitric oxide than 
uninfected macrophages. When macrophages were 
pretreated with 16 or 33 µg/ml of the aqueous extract 
prior to infection, nitric oxide production was 108.3 and 
158.3% higher than the control infected macrophages, 
respectively. When parasites were pretreated with 16 or 
33 µg/ml of the aqueous extract, nitric oxide production 
was 58.3 and 83.3% higher than the untreated infected 
macrophages, respectively.  
The pretreatment of both macrophages and parasites 
with 16 or 33 µg/ml of the aqueous extract resulted in an 
increase in nitric oxide production of 27.7 and 83.3%, 
respectively. When macrophages were infected with L. 
amazonensis 24 h prior to treatment with 16 or 33 µg/ml 
of the aqueous extract, nitric oxide production was 52.3 
and 90.4% higher than the control, respectively (Figure 
5B). 
In vivo allergy tests 
 
None of the animals tested showed any dermal or ocular 
allergic reactions to the extract, and as a consequence of 
these results, the extract was considered non-allergenic. 
 
 
DISCUSSION 
 
The current treatment regimens for leishmaniasis, which 
are based on chemotherapy, are limited and are not ideal 
because they are often associated with severe side 
effects (Tasdemir et al., 2006). The standard treatment 
for the disease is the administration of pentavalent 
antimonials. Traditional alternatives to antimonials used 
in unresponsive cases are amphotericin B and 
pentamidine, which cause serious, toxic side-effects 
(Sereno et al., 2000; Croft et al., 2006a), and the 
emergence of drug-resistant parasites presents a major 
problem   (Croft    et   al.,  2006b).  All   of   these   factors  
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Figure 5. Effects of the S. coronata aqueous extract on the nitric oxide production by mouse peritoneal macrophages. 
Parasites and/or macrophages were either treated with 16 or 33 µg/ml of S .coronata aqueous extract 20 min prior to 
macrophage-parasite co-culture or left untreated. The adherent cultured macrophages and the free parasites were washed 
once and resuspended in fresh culture medium. Intact, live L. amazonensis promastigotes were then added to the 
macrophages in culture plate wells (A). Macrophages previously infected with L. amazonensis were treated with the 
aqueous extract (16 and 33 µg/ml) for 20 min and then incubated for 90 min at 37°C in 5% CO2 (B). The supernatants from 
control and L. amazonensis–infected macrophages were collected, and the nitrite concentration of each system was 
determined by the Griess reaction, as described in Materials and Methods. Each bar represents the mean ± standard error 
of at least three independent experiments, which were performed in triplicate. The asterisk () indicates a significantly 
different value from the infected macrophages, in which neither the macrophages nor the parasites were treated with the S. 
coronata aqueous extract. (MØ) macrophages; (P) parasites; (PtMØ) pre-treated macrophages; (PtP) pre-treated 
parasites; (Post-tMØ) post-treated infected macrophages (Rodrigues et al., 2011). 
 
 
 
underscore the urgent need for new, inexpensive, safe 
and easy-to-administer substances for the treatment of 
this infectious disease. Traditional medicines have been 
used since ancient times; they are the accumulation of 
practices based on the theories, beliefs and experiences 
of different cultures. 
Traditional medicines are used for the maintenance of 
health and in the prevention, diagnosis, improvement and 
treatment of illnesses (Firenzuoli and Gori, 2007). Based 
on traditional medicine, new drugs of herbal origins 
discovered through ethnopharmacological studies have 
shown promising results. Studies focusing on herbal 
remedies useful for the treatment of leishmaniasis have 
been undertaken in French Guiana (Sauvain et al., 1996), 
Bolivia (Fournet et al., 1994), Colombia (Weniger et al., 
2001), Peru (Kvist et al., 2006) and Brazil (Muzitano et 
al., 2006). Along these lines, our laboratory has also 
initiated and developed original studies of alternative 
compounds  for  the control  of protozoan parasites (Rosa 
et al., 2003; Mendonça-Filho et al., 2004; Ueda-
Nakamura et al., 2006; de Almeida et al., 2007). In the 
course of screening for leishmanicidal compounds from 
Brazilian plants, in this work, we identified the novel 
pharmacological activity of the crude aqueous extract 
obtained from the S. coronata palm. 
Here, we showed in vitro that a crude aqueous extract 
at a concentration of 50 µg/ml killed 100% of L. 
amazonensis promastigote forms in a 60 min time course 
(Figure 2). An increased cellular volume followed by 
membrane disruption could be noted after 40 min of 
exposure, as revealed by light microscopy (Figure 3). In a 
previous study, we described the leishmanicidal activity 
of a polyphenolic-rich extract from Cocos nucifera husk 
fiber, which, at a concentration of 10 µg/ml (MIC), led to 
parasite damage after 30 min (Mendonça-Filho et al., 
2004). Similar to the present work, parasites also seemed 
to lose osmotic regulation, resulting in increased cellular 
volume  and  lysis.  Saleheena et al. (2004) demonstrated  
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the leishmanicidal activity of an aqueous onion extract 
(Allium cepa) on several strains of Leishmania 
(Saleheena et al., 2004). According to the authors, the 
aqueous extract at 1.25 mg/ml was found to be  
leishmanicidal for all of the Leishmania strains tested, 
whereas 50% of the parasites of all strains were killed at 
an average concentration of 0.376 mg/ml after 72 h of 
treatment. Here, after a 30 min incubation with S. 
coronata crude aqueous extract at 50 µg/ml, the 
parasites were no longer able to grow in fresh medium, 
suggesting irreversible metabolic damage. 
We observed that the S. coronata crude aqueous 
extract was able to reduce the association index between 
mouse peritoneal macrophages and L. amazonensis, 
with a concomitant increase in NO production in all 
systems tested (Figures 4 and 5). When macrophages 
were pre-treated with the crude aqueous extract at 33 
µg/ml, the association index was reduced approximately 
70.4% (Figure 4A), and an increase of 158.3% in NO 
production compared with the controls was detected 
(Figure 5A). Pretreatment of parasites with 33 µg/ml 
crude aqueous extract reduced the association index by 
54.3%, and NO production was 83.3% higher than the 
controls. Tiuman et al. (2005) described the 
leishmanicidal activity of parthenolide isolated from the 
hydroalcoholic extract of the aerial parts of Tanacetum 
parthenium and the survival index of intracellular 
amastigotes was reduced 50% when preinfected 
macrophages were treated with the purified parthenolide 
at 0.87 µg/ml. 
In our study, the infection of macrophages 24 h prior to 
treatment with 33 µg/ml crude aqueous extract reduced 
the association index by 71%, with a concomitant 
increase of 90.4% in NO production. Our results suggest 
that this aqueous extract likely induces the synthesis of 
NO by murine macrophages, which potentially enhances 
the killing mechanisms of these cells. Lemesre et al. 
(1997) reported the effects of authentic NO gas, which 
mimics macrophage-mediated cytotoxicity, on the in vitro 
viability and proliferation of axenically cultured amastigote 
and promastigote forms of Leishmania mexicana, L. 
amazonensis, and Leishmania chagasi. In that study, the 
authors demonstrated that NO action led to lethal 
metabolic inhibition in both parasite developmental 
stages by, at least in part, triggering iron loss from 
enzyme(s) with iron–sulfur prosthetic groups, particularly 
aconitase. Here, we observed the correlation between 
association index, NO production and parasite 
elimination, suggesting that NO could exert an important 
role in the clearance of infection. A previous report 
showed that interferon-gamma (IFN-γ) (Gantt et al., 
2001) potentiated killing of L. chagasi by macrophages 
via the induction of inducible nitric oxide synthase (iNOS); 
however, the mechanism by which the crude aqueous 
extract of S. coronata augments NO production is 
unclear. 
In the search for therapeutic agents for the treatment of  
 
 
 
 
NO-related diseases, polyphenols have been found to 
inhibit NO production (Ishii et al., 1999; Cheon et al., 
2000). Nevertheless, a number of papers have reported 
beneficial effects of polyphenols on infectious diseases 
that may be due to immunomodulatory activities, though 
the mechanism of action remains to be clarified 
(Kolodziej and Kiderlen, 2005). The leishmanicidal 
activities of phenolic compounds against Leishmania 
promastigotes and amastigotes have been described in 
several works (Mendonça-Filho et al., 2004; Kolodziej 
and Kiderlen, 2005; Kolodziej et al., 2008). 
The polyphenol content of the S. coronata aqueous 
extract was determined, and we observed that polymeric 
procyanidins (tannins) were found to be the principal 
components (Figure 1). Kiderlen et al. (2001) demonstra-
ted the leishmanicidal and immunomodulatory activities 
of a series of 28 polyphenols, which were evaluated for 
extra- and intracellular leishmanicidal activity and 
macrophage activation, including the release of NO and 
tumor necrosis factor (TNF), and for IFN-like properties. 
The potential of the polyphenols tested to induce NO 
release was moderate, ranging from 7-54 µM (IFN- γ/LPS 
119 µM). Recently, Guerra et al. (2011) described the 
immunomodulatory activity of an aqueous extract of 
babassu used as vaccine adjuvant. In that study, the 
aqueous extract (5 mg) induced the production of IFN-γ 
and NO by mouse splenocytes in vitro. Trun et al. (2006) 
demonstrated that the aqueous-ethanolic extract of the 
roots of Pelargonium sidoides (Eps® 7630) was capable 
of significantly enhancing nitric oxide synthase (iNOS) 
and cytokine mRNA levels in Leishmania-infected 
RAW264.7 cells compared to uninfected cells. The 
results reported in that study provide significant insights 
into the mode of action of plants extracts at the molecular 
level and could partially explain how phenolic 
compounds, such as polyphenols, influence the immune 
system.    
 
 
Conclusion 
 
In conclusion, drug candidates for the treatment of 
leishmaniasis should demonstrate both a direct and 
selective action on the parasites, such as stimulation of 
the host immune system, to increase the likelihood of 
clearing the infection. The toxicity of the polymeric 
procyanidin-rich crude aqueous extract toward L. 
amazonensis with concomitant macrophage activation 
and no allergic reactions in vivo, demonstrate the 
potential use of this plant as a leishmanicidal drug. 
Further investigation will be necessary to elucidate the 
relationship between phenolic compounds and the 
increased production of NO. The results presented here 
reveal a novel pharmacological activity for the 
procyanidin-rich aqueous extract from the coconut husk 
of S. coronata. However, further investigation is 
necessary  to  characterize  the  active  compounds in the  
  
 
 
aqueous extract, and such studies are currently 
underway in our laboratory.  
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